Different from the situation in HCC, the ACE2/Ang-(1-7)/Mas receptor axis can enhance glucose uptake by skeletal muscle and inhibit hepatic gluconeogenesis 50, suggesting the context-dependent roles of ACE2. Here, ACE2 is linked to hepatocellular carcinoma.